MARAbio Systems

MARAbio Systems is a precision medical biotechnology company that has developed a blood test for women to identify the presence of unique antibody clusters that cause Maternal Autoantibody-Related Autism (MARA). This enables the earliest risk assessment of autism development in children before clinical symptoms appear. The company's mission is to detect and ultimately ensure the occurrence of MARA subtypes associated with more severe forms of autism.